Fenofibrate/Simvastatin

非诺贝特/辛伐他汀

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFenofibrate/Simvastatin
Drug Alias Name辛伐他汀/非诺贝特Simvastatin/FenofibrateFenofibrate - simvastatin mistCholib
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator activated receptor agonistsHMG-CoA reductase inhibitors
TargetsPeroxisome proliferator activated receptorHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasDyslipidemias +[4] 
Global Approved IndicationsDyslipidemias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2013/08/26
Country/TerritoryCzechiaBulgariaUkraine +[23] 
CombinationsYes FenofibrateSimvastatin
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesViatris Healthcare Ltd
Inactive CompaniesAbbott LaboratoriesSolvay PharmaceuticalsOrganon & Co
Active IndicationsDyslipidemias
Inactive IndicationsHypercholesterolemiaHyperlipidemiasCardiovascular Diseases

Other Information

ATC CodeC10BA04
Related LinksKEGG